News

Terns Pharmaceuticals Encourages New Talent with Equity Grants

Terns Pharmaceuticals Encourages New Talent with Equity Grants

Terns Pharmaceuticals Encourages New Talent with Equity Grants

Terns Pharmaceuticals, Inc. is a dynamic clinical-stage biopharmaceutical company known for its innovative approach to treating serious diseases, including oncology and obesity. Recently, the company took an important step to welcome new talent into its growing team. On May 1, 2025, Terns Pharmaceutical announced the granting of equity inducement awards to two new employees, showcasing its strategy of fostering a thriving workplace culture and attracting skilled professionals within the competitive biopharmaceutical industry.

Inducement Awards Overview

The equity awards were sanctioned by the Compensation Committee of Terns’ Board of Directors, following the guidelines set forth by Nasdaq Listing Rule 5635(c)(4). These awards serve as a substantial motivation for the new hires, effectively encouraging their commitment to the company. The total number of options granted was 325,000 shares, which will enable these individuals to purchase stock in Terns at a predetermined exercise price of $3.56 per share. This price reflects the company's closing stock price on the granting date, emphasizing the potential financial growth for the new employees as they contribute to the company's mission.

Vesting Terms and Commitment

The stock options granted come with a 10-year term and will be vested over four years. This vesting schedule is designed to ensure that the new hires are incentivized to remain with the company and continue to contribute their skills and expertise to Terns’ success. Such arrangements not only bolster employee morale but can lead to reduced turnover, enhancing continuity within the team.

About Terns Pharmaceuticals

Founded with the vision to make a real difference in the world of medicine, Terns Pharmaceuticals, Inc. plays a crucial role in developing therapies that address serious health issues. The company boasts a well-rounded pipeline that includes multiple clinical-stage development programs. Within this portfolio, Terns is advancing an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, and a THR-? agonist. The development pipeline also includes efforts focused on discovery, particularly the GIPR modulator project, which is prioritizing a GIPR antagonist as its next candidate.

Innovative Approaches at Terns

Terns Pharmaceuticals remains dedicated to research and innovation, striving to deliver solutions that cater to unmet medical needs. Testament to its commitment to finding effective treatments, the company actively engages in exploring new product candidates that can significantly improve patient outcomes across various serious health conditions.

Commitment to Growth and Development

Moreover, Terns places a strong emphasis on cultivating an inclusive and growing environment for its employees. By implementing strategic inducement awards, the company acknowledges the potential of new team members and the positive influence they can bring. This initiative reflects Terns Pharmaceuticals' proactive stance in nurturing talent and fostering long-term relationships within the biopharmaceutical arena.

Contacts for Terns

Investors
Reach out to Kaytee Bock Zafereo for any investment inquiries.

Email: investors@ternspharma.com

Media
For media inquiries, please contact Jenna Urban from CG Life.

Email: media@ternspharma.com

Frequently Asked Questions

1. What are the equity inducement grants provided by Terns Pharmaceuticals?

The equity inducement grants are stock options awarded to new employees as a material incentive for accepting employment, promoting long-term commitment and engagement.

2. How many shares were granted to the new employees?

A total of 325,000 options to purchase shares were awarded to the two new employees of Terns Pharmaceuticals.

3. What is the exercise price for the stock options?

The exercise price is set at $3.56 per share, equivalent to the closing stock price of Terns Pharmaceuticals on the day the options were granted.

4. What is the vesting schedule for these stock options?

The options will vest over a four-year period, ensuring that the employees remain with the company and contribute to its growth.

5. What is Terns Pharmaceuticals’ main focus?

Terns Pharmaceuticals focuses on developing small-molecule product candidates aimed at treating serious diseases, including oncology and obesity, to improve patient outcomes significantly.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 96

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
Industrial Air Compressors: Fix, Rebuild, or Replace

Updated Category News Views 36

A compressor’s ugliest invoice is rarely the one from the service technician. It is the one nobody sees at first: a stalled production line, missed output, overtime, wasted electricity, and a maintenance crew chasing the same machine again next month. Pam Mahood of Waterloo, Iowa-based Compressed Air & Equipment Co. puts the decision where it belongs—not on the price...

Continue Reading
First Horizon Opens Its Charlotte Office in South End

Updated Category News Views 137

A Building Is Not a Balance Sheet Charlotte got a fresh First Horizon sign at 110 East Boulevard on Nov. 19, 2026, and that is a sensible move, not a magic trick. The bank has officially opened a corporate office in the city’s South End neighborhood, positioning the team to develop client relationships across the Charlotte area and broaden its regional footprint. That...

Continue Reading
CVRx Lawsuit Puts a Brutal 59.76% Drop Under Focus

Updated Category News Views 33

Sixty cents on the dollar vanished from CVRx in one trading day, and that kind of wreckage deserves more than a shrug. Shares fell $3.55, or 59.76%, to $2.39 on August 7, 2026, after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. For holders of NASDAQ:CVRX, the immediate question is not whether the chart looks...

Continue Reading
Cleveland Picks Golden Key for Citywide Leadership Training

Updated Category News Views 87

A Citywide Bet on Better Management Municipal management rarely grabs headlines until something breaks, which is precisely why Cleveland's decision to bring in Golden Key Group deserves a closer look. Announced November 20, 2026, the arrangement calls for GKG to design and deliver a citywide management training program through Cleveland's Department of Personnel and Human...

Continue Reading
Nvidia Lawsuit Allegations Put Disclosure Risk in Focus

Updated Category News Views 83

A lawsuit notice can turn a roaring chip story sour in a hurry, and this one deserves a cold, careful read rather than the usual internet stampede. DJS Law Group says it has filed a securities class action against NVIDIA, alleging that the company made materially false and misleading statements during a stated class period running from October 9, 2025 through November 8,...

Continue Reading
Mindgruve's Tech Hire Puts Sightline Growth in Focus

Updated Category News Views 67

Agency technology hires usually land with all the thunder of a stapler dropping, but this one deserves a closer look. Mindgruve has named Steve Terjeson vice president of technology, handing a former WPP Choreograph executive the job of leading its software development and data engineering teams. The assignment is not vague: push AI innovation, make the proprietary...

Continue Reading
TOP-REAL Tests Digital Monitoring in HER2 Cancer Care

Updated Category News Views 116

A cancer treatment can be extraordinarily potent and still get derailed by what happens on an ordinary Tuesday at home. That unglamorous gap between clinic visits is the whole point of TOP-REAL, a phase II academic study presented at ESMO AI & Digital Oncology 2026. Solti and its European partners are testing whether closer digital follow-up can catch trouble early enough...

Continue Reading
New York's $1.2M Prison Abuse Deal Raises State Stakes

Updated Category News Views 41

One courtroom result can expose a whole warehouse of institutional neglect, and this one lands with a grim thud. New York has agreed to pay $1.2 million to resolve a claim involving sexual assault by a former corrections officer at Bayview Correctional Facility in Manhattan. The settlement came after a two-week Adult Survivors Act bellwether trial concluded on November 17...

Continue Reading
Sports Leagues Confront Youth Gambling's Hard Truth

Updated Category News Views 7

A stadium-sized advertising machine cannot pretend kids are not watching. That is the uncomfortable backdrop to the National Council on Problem Gambling's November 10 youth gambling prevention summit, where representatives from the NFL, MLB, NBA and PGA Tour met at the NFL's New York offices. Good that they showed up. Frankly, with gambling stitched into so much sports...

Continue Reading

Top 5 Most Recently Viewed Articles

Amazon.com Options Insights: Market Sentiment Shifts in Focus

Updated Category News Views 299

Amazon.com Options Insights: Market Sentiment Shifts in Focus Investors are showing a notable optimistic stance towards Amazon.com (NASDAQ: AMZN), and ignoring this momentum would be unwise. Recent insights into options trading reveal significant movements that could signal important changes ahead. Our analysis of options data indicates that a substantial number of trades...

Continue Reading
Global Job Vacancies Decline Amid Economic Uncertainty

Updated Category News Views 278

Global Job Vacancies Experience a Notable Decrease LONDON - A recent survey highlights a decline in white-collar job vacancies worldwide, attributed to various factors such as the U.S. election, uncertainty around tax increases in the U.K., and escalating geopolitical tensions. Insights from the Recruitment Sector The monthly Global Jobs Index released by recruitment...

Continue Reading
Jura Energy Corporation Releases Interim Financial Statements

Updated Category News Views 194

Jura Energy Corporation Announces Interim Filings Release Jura Energy Corporation has announced the filing of its condensed consolidated interim financial statements as of June 30, 2024. This report details the company's financial performance for the three and six months leading up to this date. The information is available on SEDAR, along with the Management’s...

Continue Reading
Understanding the Recent Short Interest Trends for Sun Communities

Updated Category News Views 127

Analyzing Sun Communities' Short Interest Dynamics Sun Communities (NYSE: SUI) recently reported a notable change in its short interest percentage, which has seen a decrease of 5.23% since the latest report. The data indicates that currently, there are 1.38 million shares sold short, representing 1.45% of the company’s publicly available shares for trading. This...

Continue Reading
Concentric Energy Advisors Expands Team with Industry Expert

Updated Category News Views 296

Concentric Energy Advisors Welcomes New Expertise Concentric Energy Advisors, Inc. is excited to announce a significant addition to its team. The firm proudly introduces Ms. Christine Saball as the new Assistant Vice President. Recognized for her extensive background in management consulting services for the North American energy sector, Ms. Saball brings over twenty...

Continue Reading